Search

Your search keyword '"pharmacogenetics"' showing total 47,728 results

Search Constraints

Start Over You searched for: Descriptor "pharmacogenetics" Remove constraint Descriptor: "pharmacogenetics"
47,728 results on '"pharmacogenetics"'

Search Results

1. Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis

2. Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report.

3. Cost-effectiveness of pharmacogenetic screening in the management of major depressive disorder in the Spanish Healthcare System.

4. The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy.

5. SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report.

6. Advancing pharmacogenomic research in US Hmong populations: prevalence of key single nucleotide variations in California Hmong.

7. A Comparison of Molecular Techniques for Improving the Methodology in the Laboratory of Pharmacogenetics.

8. The Additive Effect of Combinations of FSH Receptor Gene Variants in Ovarian Response to Stimulation.

9. Opioids and personalized analgesia in the perioperative setting: A protocol for five systematic reviews.

10. Serious gaming as potential training tool for recognition of adverse drug reactions: side-effect exposure—medical education (SeeMe).

11. Redefining space pharmacology: bridging knowledge gaps in drug efficacy and safety for deep space missions.

12. Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics.

13. HLA-B allele frequencies and implications for pharmacogenetics in the Kuwaiti population.

14. Pharmacogenetics testing for poor response to antidepressants: a transnosographic case series.

15. Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series.

16. Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder.

17. CYP3A4*1B but Not CYP3A5*3 as Determinant of Long-Term Tacrolimus Dose Requirements in Spanish Solid Organ Transplant Patients.

18. An Inexpensive and Quick Method for Genotyping of HLA Variants Included in the Spanish Pharmacogenomic Portfolio of National Health System.

19. Common polygenic variation in the early medication change (EMC) cohort affects disorder risk, but not the antidepressant treatment response.

20. Advancing pharmacogenomic research in US Hmong populations: prevalence of key single nucleotide variations in California Hmong.

21. Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney‐transplanted patients.

22. Precision Medicine: Unveiling Progress Amidst Challenges.

23. Selección de variantes farmacogenómicas y metodología para su uso en farmacia comunitaria.

24. Normalising the Implementation of Pharmacogenomic (PGx) Testing in Adult Mental Health Settings: A Theory-Based Systematic Review.

25. Exome Sequence Data of Eight SLC Transporters Reveal That SLC22A1 and SLC22A3 Variants Alter Metformin Pharmacokinetics and Glycemic Control.

26. A Bayesian approach for investigating the pharmacogenetics of combination antiretroviral therapy in people with HIV.

27. Aging precisely: Precision medicine through the lens of an older adult.

28. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy.

29. Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population.

30. ASSOCIAÇÃO DE VARIANTES GÊNICAS E DESENVOLVIMENTO DE MUCOSITE BUCAL EM PACIENTES ONCOPEDIÁTRICOS: UMA REVISÃO NARRATIVA.

31. Smoking-Related Increases in Alcohol Outcomes and Preliminary Evidence for the Protective Effect of a Functional Nicotine Receptor Gene (CHRNA5) Variant on Alcohol Consumption in Individuals Without Alcohol Use Disorder.

32. Pharmacogenomics revolutionizing cardiovascular therapeutics: A narrative review.

33. Genomic Markers and Personalized Medicine in Androgenetic Alopecia: A Comprehensive Review.

34. Bleeding Events Associated with Rivaroxaban Therapy in Naive Patients with Nonvalvular Atrial Fibrillation: A Longitudinal Study from a Genetic Perspective with INR Follow-Up.

35. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing.

36. Targeting Calcitriol Metabolism in Acute Vitamin D Toxicity—A Comprehensive Review and Clinical Insight.

37. Update to the essential genomic nursing competencies and outcome indicators.

38. Pharmacogenetics and the Blood–Brain Barrier: A Whirlwind Tour of Potential Clinical Utility.

39. Addressing the Ethnicity Gap in Catechol O-Methyl Transferase Inhibitor Trials in Parkinson's Disease: A Review of Available Global Data.

40. Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences.

41. An Investigational Study on the Role of CYP2D6 , CYP3A4 and UGT s Genetic Variation on Fesoterodine Pharmacokinetics in Young Healthy Volunteers.

42. Association of SCN1A Polymorphisms rs3812718 and rs2298771 with Epilepsy.

43. Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis.

44. SLCO1B1 and ABCG2 genotype‐informed phenotypes are related to variation in ramipril exposure.

45. Pharmacogenetics of Toxicities Related to Endocrine Treatment in Breast Cancer: A Systematic Review and Meta-analysis.

46. Pharmacogenetic testing: current state of the issue

47. Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report

48. Association of SLC19A1 Gene Polymorphisms and Its Regulatory miRNAs with Methotrexate Toxicity in Children with Acute Lymphoblastic Leukemia

49. One Step Ahead in Realizing Pharmacogenetics in Low- and Middle-Income Countries: What Should We Do?

50. Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder

Catalog

Books, media, physical & digital resources